KLOW
Also known as KLOW Stack
Quick facts
- Researched for
- Skin appearance, gut comfort, inflammation, joint comfort and muscle recovery
- Route or form
- InjectionKLOW 80 mg: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 fragment 10 mg and KPV 10 mg
- Evidence so far
- Each finding is a report from people; no study has tested the blend itself.
- Not established
- No trial in people has tested the finished KLOW blend.
- Commonly researched
- About 3.2 to 4 mg of the blend, once dailyCommunity reportsSee every range
- Where to see it
- Listed at our partner, US Precision Peptides.Go to Next step
By the Learn Peptides editorial team · Updated · How We Research
What people are researching it for
People are researching KLOW for skin appearance, gut comfort, inflammation, joint comfort, and muscle recovery.
Four peptides. Multiple pathways. A broader approach.
- What is the KLOW Stack?
- Checklist: Often supplied in an 80 mg blend (50:10:10:10)
- Vial illustrations: GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg / KPV 10 mg, each labelled "Research Use Only". The TB-500 in a KLOW vial is the TB-500 fragment.
- Checklist: Four complementary peptides
- How does it work?
- Sections: GHK-Cu; BPC-157; TB-500; KPV
- KPV sub-box: Anti-inflammatory (NF-κB pathway)
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (and common)
- Route: Research protocols vary
- Route: Sometimes used individually or in combination
- Common blend: 80 mg total per vial
- Common blend: 50 mg GHK-Cu
- Common blend: 10 mg BPC-157
- Common blend: 10 mg TB-500
- Common blend: 10 mg KPV (ratios may vary by source)
- Typical research use: 1 to 2x per day
- Typical research use: Duration: 4 to 12 weeks (varies by goal)
- Typical research use: Often combined with proper nutrition, training, and recovery protocols
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds the same way
- Keep in mind: May help with symptoms, but long-term effects are still unknown
- Keep in mind: Use quality, independently tested products
- Key takeaway
- It's not a magic solution, but it may help you reach new goals by supporting multiple pathways in the body.
- The bottom line
- The KLOW Stack combines four peptides with complementary benefits. It may be a valuable research tool for people seeking multi-pathway support, but it's not risk-free. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
Reasons people look into KLOW. An interest is not a promise that it works.
- Skin, hair & tanning
- Gut health
- Injury & recovery
People report softer skin and gut comfort; some report no help or worse digestion.
Community reports
Reports often combine softer skin or less redness with better gut comfort, less joint discomfort, or quicker recovery. Some people report no benefit or worse digestive symptoms.
KLOW is a four-ingredient (GHK-Cu, BPC-157, TB-500 fragment and KPV) that people look at for skin appearance, gut comfort and recovery, although the blend itself has never been studied.
What this is based on
- Community reportsWhat people describe noticing. Not proof of cause.
- Learn Peptides explanationOur own plain-English summary of the sources. It is not a source itself.
Community reports
People mainly use KLOW for skin appearance, gut comfort, and joint and exercise recovery, often because they want several of these at once. Reports lean positive, but stinging at the injection site is a very common complaint, a smaller number of people describe troubling whole-body reactions, and many experienced people question the premixed vial.
Studies cover only its parts, one at a time, not the blend.
The scientific support comes from studies of the separate ingredients: GHK-Cu, KPV, BPC-157, and thymosin-related research.
No trial in people has tested the finished KLOW blend.
No has tested the finished KLOW .
Safety notes
Nobody has studied this . Stinging and lumps where it is injected are reported often, and a few people report heart or mood symptoms.
- You have trouble breathing or wheezing, or your face, lips, tongue or throat swell.
- You get hives away from the injection site, or feel severely dizzy or faint.
For these signs, call 911 or your local emergency number.
- Redness spreads, or heat, swelling or pain keeps growing where you injected.
- A lump keeps growing or does not go away, or you see pus or red streaks.
- You have a fever or chills, or feel sick all over.
- Heart disease or high blood pressure. A few people reported a pounding or racing heart and raised blood pressure while using KLOW. These are individual reports and do not show that KLOW was the cause.
- Wilson's disease or another copper-handling condition. It contains GHK-Cu, which delivers copper. People with Wilson's disease cannot clear copper.
- Cancer, now or in the past. It contains BPC-157 and TB-500. BPC-157 helps grow new blood vessels, and studies link the protein TB-500 comes from to tumor spread. Talk to your oncologist first.
- Anxiety, panic, bipolar or another mood condition. One person reported loss of pleasure, exhaustion and low motivation after KLOW, which eased after stopping. It contains BPC-157, and some people using BPC-157 report the same.
- Stinging, burning, redness, itching and lumps where it is injected are reported often enough, across unrelated communities, to treat as a real pattern.
- The says injectable GHK-Cu, the largest ingredient in the common format, has limited human safety information and raises concerns about clumping, impurities and unwanted immune reactions.
- The is not free of side effects. Some people report diarrhea, tiredness, headaches, poor sleep, heart symptoms and mood or thinking problems.
- There is no standard KLOW formula, so the amount of each ingredient can differ between sellers, and the TB ingredient may not be what the cited studies used.
- KLOW and its ingredients are not approved. An FDA advisory committee discussed three of the ingredients for in July 2026, and a committee's advice is not approval.
- Nobody has studied the KLOW itself, in people or in animals, so its benefits and risks as a combination are unknown.
- Safety is unknown. The bad reactions in the record are individual accounts with no rates and no proof of cause, and long-term safety has not been established for the or for its ingredients.
Questions to bring to your doctor
Only for the conditions this page cautions about. Bring this page with you.
- I have or had cancer. Should I avoid KLOW, and what would you watch for?
- Should I avoid KLOW with my heart or blood pressure history? What would you check before I decide?
- What mood changes on KLOW should make me stop and call you?
- Does my copper condition rule out KLOW?
Shows a community range for the 80 mg vial and the amount of each part.
Commonly researched ranges, and how they were measured.
Commonly researched range for KLOW
About 3.2 to 4 mg of the blend
once daily · Injection
Typical schedule: 4 to 12 weeks
Community reports
For the 80 mg vial (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 fragment 10 mg, KPV 10 mg), that is about GHK-Cu 2 to 2.5 mg and 400 to 500 mcg each of BPC-157, TB-500 fragment and KPV. No clinical trial has tested the four-peptide blend.
From our visual summary
Community reports
Community reports, from the Learn Peptides visual summary. These lines sit beside the ranges above and are not merged with them.
- Common blend
- 80 mg total per vial
- 50 mg GHK-Cu
- 10 mg BPC-157
- 10 mg TB-500
- 10 mg KPV (ratios may vary by source)
- Typical use
- 1 to 2 times per day
- Duration: 4 to 12 weeks (varies by goal)
- Often combined with proper nutrition, training, and recovery routines
There is no standard dose. Track how you respond, and change one thing at a time.
Check your syringe math with your own numbers.
It is a seller-made blend of 4 peptides in 1 vial, with no standard formula.
KLOW is not a single compound. It is a created by sellers and online communities that puts four peptides in one vial: GHK-Cu, BPC-157, TB-500 fragment and KPV. It is best understood as the GLOW blend with KPV added as a fourth ingredient. In the reports we reviewed, people take it by injection, and there is no standard formula, so the amount of each ingredient can differ from one seller to the next.
Not the same as
- KLOW is not the same as GLOW. GLOW is BPC-157, TB-500 fragment and GHK-Cu. KLOW is those three plus KPV, so it is a separate, four-ingredient blend.
- KLOW is not the two-ingredient mix of BPC-157 and TB-500 that communities call Wolverine, and our research review says it is not a stronger version of it. It is a broader blend, which is a different thing.
- KLOW is a blend, not one compound. An outcome someone reports while using KLOW cannot be credited to any single ingredient.
- The TB-500 in a KLOW vial should not be assumed to be full-length thymosin beta-4. Lab analysis of a commercial product sold as TB-500 found a short fragment of that protein.
- Injected GHK-Cu is not the same evidence picture as GHK-Cu applied to the skin. The human studies of GHK-Cu are mostly about skin products.
- There is no standard KLOW formula. The common ratio is a seller convention, and other ratios exist.
Next step
US Precision Peptides
KLOW 80 mg
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 fragment 10 mg + KPV 10 mg
This is a blend.
About product links
Purchases at US Precision Peptides help keep Learn Peptides free.